Results for tag: "Prograf"

Prograf is a drug used to prevent organ rejection in patients who have received a kidney, liver, or heart transplant. It is a calcineurin inhibitor, which works by suppressing the immune system to prevent it from attacking the transplanted organ. Prograf is used in combination with other immunosuppressant drugs to reduce the risk of organ rejection. It is also used to treat certain autoimmune diseases, such as rheumatoid arthritis and psoriasis. Prograf is a widely used drug in the immune disorders drugs market. It is used to treat a variety of conditions, including organ transplant rejection, autoimmune diseases, and other immune-related disorders. It is an important part of the treatment regimen for many patients, and is often prescribed in combination with other drugs. Companies in the Prograf market include Astellas Pharma, Pfizer, Novartis, and Mylan. Show Less Read more